Top News | Imaging Economics
Get this feed:
|
Public RSS feed |
|
Subscribe by email
|
First subscription
28 months ago
28 months ago
Last checked
11 hours ago
11 hours ago
Top News
Thu, Dec 04 at 07:14 AM
Top News
Page 1 of 222 223
Patient photos boost radiologists' performance Dec 2, 2008
CHICAGO (Reuters) - Radiologists often have little direct contact with patients, but showing them a photo of a test subject can help improve their performance, Israeli researchers told a meeting of the Radiological Society of North America in Chicago.
Stem cell treatment news boosts Biocompatibles Dec 2, 2008
LONDON (Reuters) - The first stroke patient treated with Biocompatibles International Plc's experimental stem cell therapy has shown no side effects following surgery, the company said on Tuesday, sending its shares up 10 percent.
NEW YORK (Reuters) - Insurer UnitedHealth Group Inc said on Tuesday it expects enrollment in its commercial health plans for employers to drop by as many as 1.5 million members next year as it holds firm on pricing and grapples with the weak economy.
U.S.-style TV drug ads a big mistake: Roche exec Dec 2, 2008
LONDON (Reuters) - U.S.-style direct advertising to consumers has been a big mistake for the global drug industry, undermining the reputation of the sector in the eyes of patients, according to a top executive at Roche.
NEW YORK (Reuters Health) - In patients with treatment-refractory temporal lobe epilepsy, the quality of life and mortality benefit from being seizure-free with surgery outweighs the risk of long-term surgical complications, investigators report in the Journal of the American Medical Association for December 3.
Russian Pharmacy Chain 36.6 swings to Q3 profit Dec 2, 2008
MOSCOW (Reuters) - Russian health and drugstore chain Pharmacy 36.6 said on Tuesday it returned to profit in the third quarter of 2008 helped by the partial sale of its real estate fund and operating improvement in its retail business.
CHICAGO (Reuters) - Medical device maker Boston Scientific Corp is not considering buying back shares and will hang on to its cash due to uncertain market conditions, its chief financial officer said on Tuesday.
Ratiopharm draws blank in German generics tender Dec 2, 2008
FRANKFURT (Reuters) - Ratiopharm, the generic-drug maker owned by embattled German billionaire Adolf Merckle, said on Tuesday it failed to secure bulk procurement contracts in the latest tender by Germany's largest healthcare insurer.
EU extends review of Teva bid for Barr Pharma Dec 2, 2008
BRUSSELS (Reuters) - The European Commission on Tuesday extended its review of Israeli drugmakerTeva Pharmaceutical's bid to acquire U.S. biopharmaceutical and generic drugs marketer Barr Pharmaceuticals Inc.
BANGALORE (Reuters) - Shares of Medicis Pharmaceutical Corp rose as much as 27 percent on Tuesday, a day after Impax Laboratories confirmed that Medicis' patents relating to acne drug Solodyn were valid and enforceable.
NEW YORK (Reuters Health) - Narrow-band imaging (NBI) cystoscopy can enhance the detection of bladder tumor recurrences in patients undergoing routine surveillance with white-light imaging (WLI) cystoscopy, new research shows.
CHICAGO (Reuters Health) - Results of magnetic resonance imaging (MRI) of the breast after radiofrequency ablation of T1 breast tumors correlate closely with what is seen on histopathological examination after surgical excision, a team from Sao Paolo, Brazil, reported here at the annual meeting of the Radiological Society of North America (RSNA 2008).
NEW YORK (Reuters Health) - Nurse-led disease management programs for secondary prevention of coronary heart disease and heart failure are cost-effective and result in improvements in health, according to findings published in the December issue of the journal Heart.
CHICAGO (Reuters Health) - In older individuals, exercise is associated with an increase in the number of large-diameter vessels in the cerebral vasculature and with an increase in blood flow in the three major cerebral arteries, researchers announced at the annual meeting of the Radiological Society of North America, which is being held here this week.
Dabur to integrate Fem Care by March: official Dec 2, 2008
MUMBAI (Reuters) - Personal care products maker Dabur India Ltd said Fem Care Pharma will become subsidiary of the company around March 2009, a top official said.
NicOx in drug production deal with DSM Dec 2, 2008
PARIS (Reuters) - French drug development firm NicOx on Tuesday said it had agreed a deal with Dutch DSM to produce the active ingredient for its Naproxcinod drug -- its main pipeline product with blockbuster potential.
Artes Medical files for Chapter 7 bankruptcy Dec 2, 2008
BANGALORE (Reuters) - Artes Medical Inc, which makes dermal fillers used in cosmetic treatments, filed for Chapter 7 bankruptcy and plans to liquidate as it has been hit by a drop in consumer spending due to the severe economic downturn.
Biolase says cutting 20 pct domestic jobs Dec 2, 2008
BANGALORE (Reuters) - U.S. medical-devices maker Biolase Technology Inc said it was cutting about 20 percent of its domestic work force and reviewing more cost savings in its international units to tackle a weak economy and capital-equipment market.
Novartis, Mylan agree on Femara generic Dec 2, 2008
ZURICH (Reuters) - Novartis AG and Mylan Inc have agreed a deal over Mylan's copy-cat version of Novartis's Femara breast cancer drug, the companies said on Tuesday.
NEW YORK (Reuters Health) - Differences in uterine leiomyomata growth may account for the higher symptom burden for black women, according to a study in the Proceedings of the National Academy of Sciences, published online ahead of print on December 1.
BANGALORE (Reuters) - Biotechnology company Alkermes Inc said its collaboration with Cephalon Inc on Vivitrol, a treatment for alcohol dependence, was terminated, and raised its 2009 earnings view to reflect revenue and expenses from Vivitrol.
NEW YORK (Reuters Health) - In prostate cancer patients treated with high-dose radiotherapy, prior transurethral resection of the prostate (TURP) is associated with an increased risk of late hematuria while long-term hormonal androgen ablation is protective, according to findings published in the November issue of Urology.
UnitedHealth gives rosier 2009 revenue forecast Dec 1, 2008
NEW YORK (Reuters) - UnitedHealth Group Inc raised the lower end of its 2009 revenue forecast on Monday, although it maintained its profit outlook for next year.
CHICAGO/NEW YORK (Reuters) - Johnson & Johnson will buy breast implant maker Mentor Corp for $1.07 billion as the diversified healthcare giant pushes into the market for cosmetic medical procedures.
CHICAGO (Reuters Health) - Breast brachytherapy not only avoids tissue contracture around breast implants in women with breast augmentation who develop breast cancer, the approach achieves better tumor control with fewer complications and entails a significantly shorter treatment course than whole breast irradiation.
1
Page 1 of 222
Wed, Dec 03 at 06:17 AM
Page 1 of 222
NEW YORK (Reuters Health) - Differences in uterine leiomyomata growth may account for the higher symptom burden for black women, according to a study in the Proceedings of the National Academy of Sciences, published online ahead of print on December 1.
BANGALORE (Reuters) - Biotechnology company Alkermes Inc said its collaboration with Cephalon Inc on Vivitrol, a treatment for alcohol dependence, was terminated, and raised its 2009 earnings view to reflect revenue and expenses from Vivitrol.
NEW YORK (Reuters Health) - In prostate cancer patients treated with high-dose radiotherapy, prior transurethral resection of the prostate (TURP) is associated with an increased risk of late hematuria while long-term hormonal androgen ablation is protective, according to findings published in the November issue of Urology.
UnitedHealth gives rosier 2009 revenue forecast Dec 1, 2008
NEW YORK (Reuters) - UnitedHealth Group Inc raised the lower end of its 2009 revenue forecast on Monday, although it maintained its profit outlook for next year.
CHICAGO/NEW YORK (Reuters) - Johnson & Johnson will buy breast implant maker Mentor Corp for $1.07 billion as the diversified healthcare giant pushes into the market for cosmetic medical procedures.
CHICAGO (Reuters Health) - Breast brachytherapy not only avoids tissue contracture around breast implants in women with breast augmentation who develop breast cancer, the approach achieves better tumor control with fewer complications and entails a significantly shorter treatment course than whole breast irradiation.
Prospects of $45 bln loan for Roche receding Dec 1, 2008
LONDON (Reuters) - The prospects of Swiss drugmaker Roche raising a $45 billion syndicated loan to finance the buyout of the rest of U.S. biotech group Genentech are becoming increasingly remote.
NEW YORK (Reuters Health) - The results of small study suggest that radiotherapy can be safely used to treat prostate cancer in HIV-infected men, having no long-term effect on CD4+ cell count or viral load.
NEW YORK (Reuters Health) - The diagnostic accuracy of MRI in children with suspected osteomyelitis or septic arthritis is not adversely affected by a prior diagnostic or surgical intervention, new research indicates.
Find a Job
Mon, Dec 01 at 03:47 AM
Featured Jobs
Saint Louis, Missouri
Hampstead, New Hampshire
Quincy, Illinois
Find a Job
Enter Keywords
Select State
Page 1 of 222
Sat, Nov 29 at 10:43 PM
Page 1 of 222
NEW YORK (Reuters Health) - The diagnostic accuracy of MRI in children with suspected osteomyelitis or septic arthritis is not adversely affected by a prior diagnostic or surgical intervention, new research indicates.
Goldshield H1 revenues up 23 pct Nov 28, 2008
LONDON (Reuters) - British pharmaceutical and health company Goldshield said on Friday half-year revenues increased by 23 percent, after strong growth in its pharmaceutical and consumer health products.
EU accuses drugmakers of blocking cheaper generics Nov 28, 2008
BRUSSELS/LONDON (Reuters) - Major drug companies are delaying or blocking the entry of cheaper generic medicines, pushing up bills for taxpayers and reducing the incentive for innovation, the European Commission said on Friday.
Arpida shares rally on job cut plans Nov 28, 2008
ZURICH (Reuters) - Shares in Arpida rallied over 20 percent on Friday after the Swiss biotech company said it was slashing jobs in the wake of a negative opinion on approving its lead drug candidate in the United States.
Novartis CEO sees higher dividend in future: TV Nov 28, 2008
ZURICH (Reuters) - Novartis AG could increase its dividend and also resume share buybacks once it has reduced its debt, the head of the Swiss drugmaker said in an interview published on Friday.
NEW YORK (Reuters Health) - Although multidetector CT angiography can accurately assess the presence and severity of coronary disease and identify patients who will require revascularization, its relatively low negative and positive predictive values mean that it cannot yet replace conventional angiography.
Featured Jobs
Fri, Nov 28 at 08:18 PM
Featured Jobs
King of Prussia, Pennsylvania
Hampstead, New Hampshire
Saint Louis, Missouri
Here's the start of Feedwhip's latest snapshot
taken Thu, Dec 04 at 07:14 AM
[image: spacer.gif]
[image: spacer.gif]
[image: spacer.gif]
[image: logo_ascend_media.gif] [image: logo.gif]
Search
[image: bullet_arrows.gif] About IE
[image: bullet_arrows.gif] Contact Us
[image: bullet_arrows.gif] Subscribe
[image: bullet_arrows.gif] Read Weekly eNewsletter
[image: spacer.gif]
[image: spacer.gif]
HOME | NEWS | CURRENT ISSUE | BUYER'S GUIDE | ARCHIVES | CALENDAR | RESOURCES | CAREERS
[image: spacer.gif] [image: spacer.gif] [image: spacer.gif]
Top News
Page 1 of 223[image: icon_file.gif] Patient photos boost radiologists' performance Dec 2, 2008 CHICAGO (Reuters) - Radiologists often have little direct contact with patients, but showing them a photo of a test subject can help improve their performance, Israeli researchers told a meeting of the Radiological Society of North America in Chicago.
[image: icon_file.gif] Stem cell treatment news boosts Biocompatibles Dec 2, 2008 LONDON (Reuters) - The first stroke patient treated with Biocompatibles International Plc's experimental stem cell therapy has shown no side effects following surgery, the company said on Tuesday, sending its shares up 10 percent.
[image: icon_file.gif] UnitedHealth sees commercial enrollment down in '09 Dec 2, 2008 NEW YORK (Reuters) - Insurer UnitedHealth Group Inc said on Tuesday it expects enrollment in its commercial health plans for employers to drop by as many as 1.5 million members next year as it holds firm on pricing and grapples with the weak economy.
[image: icon_file.gif] U.S.-style TV drug ads a big mistake: Roche exec Dec 2, 2008 LONDON (Reuters) - U.S.-style direct advertising to consumers has been a big mistake for the global drug industry, undermining the reputation of the sector in the eyes of patients, according to a top executive at Roche.
[image: icon_file.gif] Surgery for refractory epilepsy improves life expectancy and quality of life Dec 2, 2008 NEW YORK (Reuters Health) - In patients with treatment-refractory temporal lobe epilepsy, the quality of life and mortality benefit from being seizure-free with surgery outweighs the risk of long-term surgical complications, investigators report in the Journal of the American Medical Association for December 3.
[image: icon_file.gif] Russian Pharmacy Chain 36.6 swings to Q3 profit Dec 2, 2008 MOSCOW (Reuters) - Russian health and drugstore chain Pharmacy 36.6 said on Tuesday it returned to profit in the third quarter of 2008 helped by the partial sale of its real estate fund and operating improvement in its retail business.
[image: icon_file.gif] Boston Scientific says no plans for share buyback Dec 2, 2008 CHICAGO (Reuters) - Medical device maker Boston Scientific Corp is not considering buying back shares and will hang on to its cash due to uncertain market conditions, its chief financial officer said on Tuesday.
[image: icon_file.gif] Ratiopharm draws blank in German generics tender Dec 2, 2008 FRANKFURT (Reuters) - Ratiopharm, the generic-drug maker owned by embattled German billionaire Adolf Merckle, said on Tuesday it failed to secure bulk procurement contracts in the latest tender by Germany's largest healthcare insurer.
[image: icon_file.gif] EU extends review of Teva bid for Barr Pharma Dec 2, 2008 BRUSSELS (Reuters) - The European Commission on Tuesday extended its review of Israeli drugmakerTeva Pharmaceutical's bid to acquire U.S. biopharmaceutical and generic drugs marketer Barr Pharmaceuticals Inc.
[image: icon_file.gif] Medicis shares soar after patent settlement with Impax Dec 2, 2008 BANGALORE (Reuters) - Shares of Medicis Pharmaceutical Corp rose as much as 27 percent on Tuesday, a day after Impax Laboratories confirmed that Medicis' patents relating to acne drug Solodyn were valid and enforceable.
[image: icon_file.gif] Narrow-band imaging cystoscopy improves detection of bladder tumor recurrence Dec 2, 2008 NEW YORK (Reuters Health) - Narrow-band imaging (NBI) cystoscopy can enhance the detection of bladder tumor recurrences in patients undergoing routine surveillance with white-light imaging (WLI) cystoscopy, new research shows.
[image: icon_file.gif] ...
